These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25131987)

  • 1. Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise.
    Phillips AA
    J Clin Hypertens (Greenwich); 2014 Oct; 16(10):768. PubMed ID: 25131987
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise.
    Gkaliagkousi E; Gavriilaki E; Douma S
    J Clin Hypertens (Greenwich); 2014 Oct; 16(10):769. PubMed ID: 25098956
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness.
    Georgianos PI; Sarafidis PA; Zebekakis PE
    J Clin Hypertens (Greenwich); 2014 Jul; 16(7):475-6. PubMed ID: 24837170
    [No Abstract]   [Full Text] [Related]  

  • 4. Exercise-induced pulse wave velocity changes in untreated patients with essential hypertension: the effect of an angiotensin receptor antagonist.
    Gkaliagkousi E; Gavriilaki E; Nikolaidou B; Triantafyllou G; Douma S
    J Clin Hypertens (Greenwich); 2014 Jul; 16(7):482-7. PubMed ID: 24853292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients.
    Munakata M; Nagasaki A; Nunokawa T; Sakuma T; Kato H; Yoshinaga K; Toyota T
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1050-5. PubMed ID: 15533733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hope in Life and Value of blood pressure control.
    Ruilope LM; Segura J
    J Hypertens; 2004 Dec; 22(12):2265-6. PubMed ID: 15614017
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin receptor blockers: baseline therapy in hypertension?
    Messerli FH; Bangalore S; Ruschitzka F
    Eur Heart J; 2009 Oct; 30(20):2427-30. PubMed ID: 19723696
    [No Abstract]   [Full Text] [Related]  

  • 8. Valuable lessons from VALUE.
    Hedner T; Kjeldsen SE; Himmelmann A
    Blood Press; 2004; 13(4):196-7. PubMed ID: 15581332
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
    Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
    Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [VALISH].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():454-8. PubMed ID: 16981579
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sartans for hypertension--implications of the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
    Cheung BM
    Hong Kong Med J; 2004 Oct; 10(5):359. PubMed ID: 15479968
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood-pressure reduction with LCZ696.
    Waeber B; Feihl F
    Lancet; 2010 Apr; 375(9722):1228-9. PubMed ID: 20236699
    [No Abstract]   [Full Text] [Related]  

  • 15. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.
    Mahmud A; Feely J
    J Hum Hypertens; 2000 Sep; 14(9):541-6. PubMed ID: 10980584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 17. [Convincing results from the JIKEI Study].
    MMW Fortschr Med; 2006 Dec; 148(51-52):55. PubMed ID: 17619349
    [No Abstract]   [Full Text] [Related]  

  • 18. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 19. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract]   [Full Text] [Related]  

  • 20. The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension.
    Kjeldsen SE; Narkiewicz K; Hedner T
    Blood Press; 2009; 18(5):240-1. PubMed ID: 19919393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.